At what cumulative paclitaxel dose does severe neuropathy typically occur?

Grade 3 neuropathy typically emerges after cumulative doses of 1,000–1,400 mg/m2 with weekly paclitaxel or 6+ cycles of 3-weekly 175 mg/m2. Risk is higher with pre-existing diabetes, prior neurotoxic therapy, and alcohol use.

Is nab-paclitaxel less neurotoxic than solvent-based paclitaxel?

Nab-paclitaxel (Abraxane) causes peripheral neuropathy at similar or higher rates but without Cremophor-related hypersensitivity. Grade 3+ sensory neuropathy occurs in approximately 10% of patients on weekly nab-paclitaxel at 100–125 mg/m2.

Paclitaxel Neuropathy Cumulative Risk

Assess peripheral neuropathy risk from cumulative paclitaxel exposure, with dose modification thresholds: grade 2 neuropathy warrants 20% dose reduction; grade 3 neuropathy requires treatment hold.

Use the full interactive calculator below, or

Related Calculators

Docetaxel Edema

Medical Long-tail

Vincristine Limit

Medical Long-tail

Paclitaxel Neuropathy Cumulative Risk

Related Calculators

Frequently Asked Questions

At what cumulative paclitaxel dose does severe neuropathy typically occur?

Is nab-paclitaxel less neurotoxic than solvent-based paclitaxel?